Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals

The Meniere attack: an ischemia/reperfusion disorder of inner ear sensory tissues.

Medical hypotheses·2013

Production of terminally differentiated neuroblastoma cells in culture.

Restorative neurology and neuroscience·2011

Osteochondroma of the convexity: pathologic-neuroimaging correlates of a lesion that mimics high-grade meningioma.

Journal of neuro-oncology·2009

Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity.

Journal of inherited metabolic disease·2006

An overview of central nervous system transplantation in human disease.

Neurosurgical focus·2006

A cross-sectional study of triallate exposure and neurological health among workers at a pesticide manufacturing and formulating facility.

Occupational and environmental medicine·2004

Behavior therapy: other interventions for tic disorders.

Advances in neurology·2006

Treatment of aggression in Tourette syndrome.

Advances in neurology·2006

Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.

Advances in neurology·2006

Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.

Advances in neurology·2006

Preclinical models relevant to Tourette syndrome.

Advances in neurology·2006

Transforming Plant Viruses into Vectors for Next-Generation Agriculture-A Review.

Current microbiology·2026

Tobamoviruses: Advances in Molecular Biology, Host Interactions and Integrated Disease Management.

Biology·2026

Efficient genome editing in tomato using Cas12i3 variants.

Journal of integrative plant biology·2026

Immunogenicity of a Vero cell-adapted Japanese encephalitis attenuated virus strain SA14-14-2 VC6.

Archives of virology·2026

Maize Developmental Biology: Fundamental Discoveries Unlocking Innovation.

Cold Spring Harbor protocols·2026

T-2 toxin-induced neurotoxicity in juvenile rats involves hippocampal oxidative stress-ER stress-mediated neuronal apoptosis and potential gut-brain axis involvement.

Chemico-biological interactions·2026

Related Experiment Videos

Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve

Related Concept Videos

The Meniere attack: an ischemia/reperfusion disorder of inner ear sensory tissues.

Production of terminally differentiated neuroblastoma cells in culture.

Osteochondroma of the convexity: pathologic-neuroimaging correlates of a lesion that mimics high-grade meningioma.

Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity.

An overview of central nervous system transplantation in human disease.

A cross-sectional study of triallate exposure and neurological health among workers at a pesticide manufacturing and formulating facility.

Behavior therapy: other interventions for tic disorders.

Treatment of aggression in Tourette syndrome.

Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.

Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.

Preclinical models relevant to Tourette syndrome.

Transforming Plant Viruses into Vectors for Next-Generation Agriculture-A Review.

Tobamoviruses: Advances in Molecular Biology, Host Interactions and Integrated Disease Management.

Efficient genome editing in tomato using Cas12i3 variants.

Immunogenicity of a Vero cell-adapted Japanese encephalitis attenuated virus strain SA14-14-2 VC6.

Maize Developmental Biology: Fundamental Discoveries Unlocking Innovation.

T-2 toxin-induced neurotoxicity in juvenile rats involves hippocampal oxidative stress-ER stress-mediated neuronal apoptosis and potential gut-brain axis involvement.

Related Experiment Videos

Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve...

Related Concept Videos

Related Articles

Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve